These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor gamma expression and adipogenesis in cultured 3T3-L1 cells. Christianson JL; Nicoloro S; Straubhaar J; Czech MP J Biol Chem; 2008 Feb; 283(5):2906-16. PubMed ID: 18032385 [TBL] [Abstract][Full Text] [Related]
5. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice. Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632 [TBL] [Abstract][Full Text] [Related]
6. Pioglitazone-induced increase in the stearoyl-CoA desaturation index and fat accumulation in rat muscles are not related to lipoprotein lipase activity. Ochiai M; Matsuo T J Oleo Sci; 2013; 62(9):745-54. PubMed ID: 24005019 [TBL] [Abstract][Full Text] [Related]
7. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. Yao-Borengasser A; Varma V; Bodles AM; Rasouli N; Phanavanh B; Lee MJ; Starks T; Kern LM; Spencer HJ; Rashidi AA; McGehee RE; Fried SK; Kern PA J Clin Endocrinol Metab; 2007 Jul; 92(7):2590-7. PubMed ID: 17595259 [TBL] [Abstract][Full Text] [Related]
8. Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone. Yao-Borengasser A; Varma V; Coker RH; Ranganathan G; Phanavanh B; Rasouli N; Kern PA Metabolism; 2011 Jul; 60(7):1012-20. PubMed ID: 21129760 [TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Risérus U; Tan GD; Fielding BA; Neville MJ; Currie J; Savage DB; Chatterjee VK; Frayn KN; O'Rahilly S; Karpe F Diabetes; 2005 May; 54(5):1379-84. PubMed ID: 15855323 [TBL] [Abstract][Full Text] [Related]
10. Regulation of small ubiquitin-like modifier-1, nuclear receptor coreceptor, histone deacetylase 3, and peroxisome proliferator-activated receptor-γ in human adipose tissue. Finlin BS; Bodles-Brakhop AM; Yao-Borengasser A; Zhu B; Starnes CP; McGehee RE; Peterson CA; Kern PA; Rasouli N Metab Syndr Relat Disord; 2012 Aug; 10(4):312-7. PubMed ID: 22651256 [TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo. Mai K; Andres J; Bobbert T; Assmann A; Biedasek K; Diederich S; Graham I; Larson TR; Pfeiffer AF; Spranger J Metabolism; 2012 Jan; 61(1):108-16. PubMed ID: 21741058 [TBL] [Abstract][Full Text] [Related]
12. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro. Pinnamaneni SK; Southgate RJ; Febbraio MA; Watt MJ Diabetologia; 2006 Dec; 49(12):3027-37. PubMed ID: 17033839 [TBL] [Abstract][Full Text] [Related]
13. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521 [TBL] [Abstract][Full Text] [Related]
14. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways. Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. Unal R; Yao-Borengasser A; Varma V; Rasouli N; Labbate C; Kern PA; Ranganathan G J Clin Endocrinol Metab; 2010 Jun; 95(6):2993-3001. PubMed ID: 20392866 [TBL] [Abstract][Full Text] [Related]
17. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart. Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664 [TBL] [Abstract][Full Text] [Related]
18. Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression. Zhu X; Yan H; Xia M; Chang X; Xu X; Wang L; Sun X; Lu Y; Bian H; Li X; Gao X Lipids Health Dis; 2018 May; 17(1):114. PubMed ID: 29759071 [TBL] [Abstract][Full Text] [Related]
19. Adipose-specific deletion of stearoyl-CoA desaturase 1 up-regulates the glucose transporter GLUT1 in adipose tissue. Hyun CK; Kim ED; Flowers MT; Liu X; Kim E; Strable M; Ntambi JM Biochem Biophys Res Commun; 2010 Sep; 399(4):480-6. PubMed ID: 20655875 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor. Tao H; Aakula S; Abumrad NN; Hajri T Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E68-79. PubMed ID: 19861583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]